Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: A prospective randomized pilot study

Journal of Korean Medical Science

Volumn 25, Issue 4, 2010, Pages 583-588

  Kim, Yu Jin ^a   Cheon, Jae Hee ^a   Lee, Sang Kil ^a   Kim, Jie Hyun ^a   Lee, Yong Chan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Endoscopic mucosal resection; H2 receptor antagonist; Rebamipide; Stomach ulcer

Indexed keywords

ALANINE; ANTIULCER AGENT; DRUG DERIVATIVE; FAMOTIDINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; QUINOLONE DERIVATIVE; REBAMIPIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL ENDOSCOPY; HUMAN; IATROGENIC DISEASE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; ALANINE; ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; FAMOTIDINE; HISTAMINE H2 ANTAGONISTS; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; QUINOLONES; RECEPTORS, HISTAMINE H2; STOMACH ULCER; WOUND HEALING;

EID: 77954026828     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.4.583     Document Type: Article

References (22)

1. Conio M, Ponchon T, Blanchi S, Filiberti R. Endoscopic mucosal resection. Am J Gastroenterol 2006; 101: 653-63.
2. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48: 225-9.
3. Lee JH, Kim JJ. Endoscopic mucosal resection of early gastric cancer: Experiences in Korea. World J Gastroenterol 2007; 13: 3657-61.
4. Tanaka M, Ono H, Hasuike N, Takizawa K. Endoscopic submucosal dissection of early gastric cancer. Digestion 2008; 77 (Suppl 1): 23-8.
5. Wallace JL. Recent advances in gastric ulcer therapeutics. Curr Opin Pharmacol 2005; 5: 573-7.
6. Szabo S, Vincze A, Sandor Z, Jadus M, Gombos Z, Pedram A, Levin E, Hagar J, Iaquinto G. Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF. Dig Dis Sci 1998; 43 (9 Suppl): 40S-45S.
7. Esaki M, Aoyagi K, Matsumoto T, Kuwano Y, Shimizu M, Fujishima M. Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. Eur J Gastroenterol Hepatol 2002; 14: 365-9.
8. Piazuelo E, Lanas A, Jimenez P, García-Gonzalez A, Esteva F. In vitro wound repair by human gastric fibroblasts: implications for ulcer healing. Dig Dis Sci 1998; 43: 1230-40.
9. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci 1998; 43 (9 Suppl): 5S-13S.
10. Tarnawski AS, Chai J, Pai R, Chiou SK. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angio-genesis: a key to its ulcer healing action? Dig Dis Sci 2004; 49: 202-9.
11. Sakita T, Fukutomi H. Endoscopic diagnosis. In: Yoshitoshi Y, editor. Ulcer of the stomach and duodenum. Tokyo: Nankodo 1971; 198-208.
12. Ye BD, Cheon JH, Choi KD, Kim SG, Kim JS, Jung HC, Song IS. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. Aliment Pharmacol Ther 2006; 24: 837-43.
13. Lee SY, Kim JJ, Lee JH, Kim YH, Rhee PL, Paik SW, Rhee JC. Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc 2004; 60: 213-7.
14. Bate CM, Wilkinson SP, Bradby GV, Bateson MC, Hislop WS, Crowe JP, Willoughby CP, Peers EM, Richardson PD. Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut 1989; 30: 1323-8.
15. Walan A, Bader JP, Classen M, Lamers CB, Piper DW, Rutgersson K, Eriksson S. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69-75.
16. Schepp W, Classen M. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. Scand J Gastroenterol 1995; 30: 511-4.
17. Lauritsen K, Rune SJ, Wulff HR, Olsen JH, Laursen LS, Havelund T, Astrup L, Bendtsen F, Linde J, Bytzer P. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. Gut 1988; 29: 249-53.
18. Lauritsen K, Rune SJ, Bytzer P, Kelbaek H, Jensen KG, Rask-Madsen J, Bendtsen F, Linde J, Hojlund M, Andersen HH. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med 1985; 312: 958-61.
19. Yamaguchi Y, Katsumi N, Tauchi M, Toki M, Nakamura K, Aoki K, Morita Y, Miura M, Morozumi K, Ishida H, Takahashi S. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration. Aliment Pharmacol Ther 2005; 21 (Suppl 2): S111-5.
20. Kojima T, Parra-Blanco A, Takahashi H, Fujita R. Outcome of endoscopic mucosal resection for early gastric cancer: review of the Japanese literature. Gastrointest Endosc 1998; 48: 550-4.
21. Jang JS, Lee EJ, Lee SW, Lee JH, Roh MH, Han SY, Choi SR, Jeong JS. Endoscopic submucosal dissection for early gastric cancer and gastric adenoma. Korean J Gastroenterol 2007; 49: 356-63.
22. Maity P, Biswas K, Roy S, Banerjee RK, Bandyopadhyay U. Smoking and the pathogenesis of gastroduodenal ulcer-recent mechanistic update. Mol Cell Biochem 2003; 253: 329-38.